Dr Mark Beggs - Chief Executive
Mark joined UK Biocentre in July 2016 as Managing Director becoming Chief Executive in 2017.
Mark holds a PhD in Clinical Biochemistry and a BA in Biochemistry both from Oxford University.
Prior to UK Biocentre, he developed significant experience in managing academic/industry collaborations
as Chief Executive of Stratified Medicine
Scotland, a nationally co-ordinated genomic medicine initiative, and previously as Programme
Manager of Pfizer’s (former Wyeth) Translational Medicine Research Collaboration programme.
Prior to this, Mark was Head of Consulting at TAP Biosystems (as The Automation Partnership) in
Cambridgeshire UK for eight years where he led a consulting team in delivering major change
programmes for clients within Pharma Discovery and Biological production with particular focus on
the application of manufacturing consultancy techniques in a Pharma Discovery environment.
Mark has an additional ten year’s direct experience in early stage Pharma Discovery roles, having
worked variously for GSK (as Glaxo) in North Carolina USA, Astra Zeneca (as Zeneca) in Alderley Park,
UK and J&J in Beerse, Belgium where he was Director of HTS. In these roles he developed significant
experience in the design and deployment of automated systems for life science applications and in
Back to management team